Live Breaking News & Updates on Neumora Therapeutics Daily
Stay updated with breaking news from Neumora therapeutics daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bank of America initiated coverage on shares of Neumora Therapeutics (NASDAQ:NMRA – Free Report) in a research note released on Tuesday, Marketbeat Ratings reports. The brokerage issued a buy rating and a $18.00 price target on the stock. NMRA has been the topic of a number of other research reports. Royal Bank of Canada assumed […] ....
Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) have received a consensus rating of “N/A” from the zero research firms that are covering the stock, MarketBeat Ratings reports. NMRA has been the subject of a number of research reports. Royal Bank of Canada assumed coverage on Neumora Therapeutics in a research note on […] ....
JPMorgan Chase & Co. started coverage on shares of Neumora Therapeutics (NASDAQ:NMRA – Get Free Report) in a research report issued to clients and investors on Tuesday, Marketbeat Ratings reports. The firm set an “overweight” rating and a $21.00 price target on the stock. JPMorgan Chase & Co.‘s target price points to a potential upside […] ....
Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report)’s stock price was down 8% on Tuesday . The stock traded as low as $10.55 and last traded at $10.98. Approximately 189,086 shares were traded during trading, a decline of 62% from the average daily volume of 496,051 shares. The stock had previously closed at $11.94. Analyst […] ....
Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) major shareholder Arch Venture Partners Xii, Llc purchased 24,504 shares of the business’s stock in a transaction on Wednesday, September 27th. The stock was acquired at an average price of $12.31 per share, for a total transaction of $301,644.24. Following the completion of the purchase, the insider […] ....